The application of Oct4 CM, c-Myc CM, and Oct4/c-Myc CM to tumor cells reduced the proliferation, migration, invasion, and growth of three-dimensional tumor spheroids, and in the mouse models, the systemic administration of CMs inhibited the growth of mammary tumors and bone degradation. Here, POU5F1 is linked to neoplasm.